Speaker illustration

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

Member of:

European Society of Cardiology

Balancing safety and efficacy of oral anticoagulation in patients with atrial fibrillation undergoing cardiac interventions

Event: ESC CONGRESS 2019

Topic: Treatment

Session type: Practical Tutorials

Thumbnail

Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Increasing the awareness for thrombosis: worldwide challenges and global initiatives

Event: ESC CONGRESS 2017

Topic: Thrombosis and coagulation

Session type: Symposium

Thumbnail

Managing patients with pulmonary embolism after hospital discharge... Considering the evidence for anticoagulation

Event: ESC CONGRESS 2017

Topic: Acute pulmonary embolism

Session type: Satellite Symposium

Thumbnail

The changing landscape of oral anticoagulation for atrial fibrillation

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Emerging options for patients with atrial fibrillation

Event: ESC CONGRESS 2014

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

The changing landscape in oral anticoagulation – The last pieces of the puzzle

Event: ESC Congress 2013

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk